In a phase 1b trial in #GastroesophagealCancer , neoadjuvant nivolumab or nivolumab/relatlimab prior chemoradiotherapy were well tolerated and liquid biopsy analyses show that undetectable ctDNA was associated with longer survival Elsa Anagnostou Vincent Lam
nature.com/articles/s4159…

Clinical Trial Results Published in Nature Medicine Show Immunotherapy's Potential in ... - goo.gl/alerts/ccHd2U #GoogleAlerts

Out in Nature Medicine our phase Ib study of neoadjuvant nivo/nivo+LAG-3 + chemoRT in esoph/GEJ cancer; linking ctDNA w path/immune responses and RFS. nature.com/articles/s4159… Elsa Anagnostou Johns Hopkins Thoracic Oncology Conquer Cancer, the ASCO Foundation #esophagealcancer 1/5

Thank you to Dak Prescott and all the Dallas Cowboys for helping our team at Baylor Scott & White Health to raise awareness about the importance of cancer screening and early detection. Empowering you to live well #MyCauseMyCleats

Your superpower? Early detection. Watch the story that inspired Dak’s #MyCauseMyCleats and schedule your early screening today at bit.ly/40Z6NxW

Updates today 1-2pm CST from the newly published SITC clinical practice guidelines for the use of IO across all GI malignancies. Please join myself, Dr Kristen Ciombor, Dr Scott Paulson and Dr Manish Shah.

Updates today 1-2pm CST from the newly published SITC clinical practice guidelines for the use of IO across all GI malignancies. Please join myself, Dr Kristen Ciombor, Dr Scott Paulson and Dr Manish Shah.

Congratulations to all the team Baylor Scott & White Health for another highly successful Celebrating Women Luncheon. A huge thank you to LeAnn Rimes world famous singer, songwriter, actress and breast cancer advocate for supporting our breast cancer program in Texas. Over $40m now raised…

About to start webinar with Dr. Geoffrey Ku and Ronan Kelly re: Society for Immunotherapy of Cancer 2023 Guidelines for #GI #cancer about to start at 4PM CST. #Immunotherapy #Cancer Research #Cancer #PatientCare Memorial Sloan Kettering Cancer Center Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center

Congratulations to everyone at the Charles A. Sammons Cancer Center and the T. Boone Pickens Cancer Hospital at Baylor University Medical Center in Dallas. Rising 59 places amongst the top 100 cancer centers in the US over the last 4 years is an extraordinary achievement.

Adj nivolumab vs plc in resected esophageal or GEJ cancer following neoadjuvant CRT: biomarker analyses from CheckMate 577 by R. Kelly at #WCGIC2023
👉Benefit in multiple (inflammatory) subgroups
👉Increased PDL-1 expression in 51% post-CRT
ESMO - Eur. Oncology World Congress on Gastrointestinal Cancer

Congrats to Ronan Kelly for a great presentation at #WCGIC2023 and moving the needle in understanding the role of adjuvant checkpoint inhibitor in esophageal and GEJ cancers! EC Aware Esophageal Cancer RF

A privilege on behalf of the study team to report exploratory biomarkers from CM577 at #WCGIC2023
👉largest BM dataset in this setting
👉GES can predict benefit
👉DFS benefit across all mutations
👉XRT priming effect on PDL1 shown for 1st time
ESMO - Eur. Oncology Baylor Scott & White Health Society for Immunotherapy of Cancer

We’re pleased to announce new collaborations with Broad Institute of MIT, Harvard University, and Baylor Scott & White Health to advance innovative cancer technologies and approaches. Read more about each agreement: exas.co/469TsoZ